Therapies
Saturday, July 5th, 2014
JAHA: June 17, 2014 Background Assessing hospital quality in the performance of carotid endarterectomy (CEA) requires appropriate risk adjustment across hospitals with varying case mixes. The aim of this study was to develop and validate a prediction model to assess the risk of in‐hospital stroke or death after CEA that could aid in the assessment of hospital […]
Therapies
Saturday, July 5th, 2014
J Am Heart Assoc.: June 5, 2014 Background Treatment with the combination of clopidogrel and aspirin taken soon after a transient ischemic attack (TIA) or minor stroke was shown to reduce the 90‐day risk of stroke in a large trial in China, but the cost‐effectiveness is unknown. This study sought to estimate the cost‐effectiveness of the clopidogrel‐aspirin […]
Therapies
Saturday, July 5th, 2014
Wiley: 2 JUN 2014 Funding: Professor Thorsten Steiner has received honoraria from Boehringer, Bayer, and BMS–Pfizer. Professor Bo Norrving has acted as consultant for Bayer HealthCare, Servier, Syngis, Daichii Sankyo and Allergan, and has received royalties for a book published by Karolinska University Press. Professor Graeme Hankey has received honoraria for serving on the executive committees […]
Therapies
Saturday, July 5th, 2014
STROKEAHA: June 19, 2014 After rehabilitation, most stroke survivors return to the community and continue with their daily lives, despite stroke-related functional, cognitive, and behavioral changes.1Caregivers are the primary support system for these survivors after discharge and an integral part of the healthcare team that contributes to survivors’ rehabilitation and recovery.2,3 However, caregiving is stressful, and caregivers […]
Therapies
Saturday, July 5th, 2014
STROKEAHA: May 29, 2014 Making decisions in medical care is a difficult task, involving a variety of cognitive processes. Decision making is defined as the process of examining possibilities, risks, uncertainties, and options, comparing them, and choosing a course of action.1,2 Decisions based on erroneous assessments may result in incorrect patient and family expectations, and potentially inappropriate […]
Therapies
Saturday, July 5th, 2014
STROKEAHA: May 29, 2014 Background and Purpose—Early neurological deterioration (END) after anterior circulation stroke is a serious clinical event strongly associated with poor outcome. Regarding specifically END occurring within 24 hours of intravenous recombinant tissue-type plasminogen activator, apart from definite causes such as symptomatic intracranial hemorrhage and malignant edema whose incidence, predictors, and clinical management are […]
Therapies
Saturday, July 5th, 2014
STROKEAHA: April 24, 2014 The delivery of medical care through telecommunication has been available in one form or another for ≈100 years. In the early 1900s, people living in remote areas of Australia used 2-way radios (powered by dynamos and bicycle pedals) to communicate with the Australian Royal Flying Doctor Service. The first direct reference to […]
Guidelines, Therapies
Saturday, July 5th, 2014
AHA – Circulation: March 27, 2014 A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines Traditionally, resource utilization and value considerations have been explicitly excluded from practice guidelines and performance measures formulations, although they often are implicitly considered. This document challenges this historical policy. With […]
Therapies
Monday, June 9th, 2014
A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Purpose—This scientific statement provides an overview of the evidence on physical activity and exercise recommendations for stroke survivors. Evidence suggests that stroke survivors experience physical deconditioning and lead sedentary lifestyles. Therefore, this updated scientific statement serves as an overall guide for practitioners […]
Therapies
Monday, June 9th, 2014
STROKEAHA: May 15, 2014 Background and Purpose—The aim was to investigate the risk of intracerebral hemorrhage (ICH) in patients with ischemic stroke taking warfarin and whether this risk changed over time. Methods—Between 2001 and 2008, the Swedish Stroke Register registered 12 790 patients with ischemic stroke discharged on warfarin. The patients was studied in two 4-year […]
